Mayo Clinc’s VTE prevention recognized by Centers for Disease Control and Prevention
A Mayo Clinic team was recognized by the Centers for Disease Control and Prevention (CDC) in its Healthcare-associated Venous Thromboembolism Prevention Challenge, or VTE prevention. The efforts of six institutions are covered in a December 2016 supplement to the Journal of Hospital Medicine titled “Preventing Hospital-Acquired Venous Thromboembolism: Lessons from the Field.”
Mayo Clinic’s contribution, “Preventing Acute Care-Associated Venous Thromboembolism in Adult and Pediatric Patients Across a Large Healthcare System,” was authored by Timothy Morgenthaler, M.D. (I ’91, THD ’94), Division of Pulmonary and Critical Care Medicine; and Vilmarie Rodriguez, M.D. (PDHO ’99), Division of Pediatric Hematology-Oncology.
Dr. Rodriguez followed Dr. Morgenthaler’s steps in designing and implementing VTE orders to apply to pediatric patients throughout Mayo’s hospitals. “Prevention of hospital-acquired conditions in hospitalized children is an ongoing priority among many children’s centers, and VTE is one of those complications that can be life-threatening,” she says. “We are in the early stages of enforcing VTE screening and prevention and implementing electronic orders for this purpose. Educating our pediatric trainees and providers is a priority.”